Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

[1]  P. Syrris,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy , 2009 .

[2]  Petros Syrris,et al.  Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.

[3]  P. Syrris,et al.  Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease. , 2006, European heart journal.

[4]  P. Ellinor,et al.  Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. , 2006, American journal of human genetics.

[5]  D. Pennell,et al.  Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. , 2006, Journal of the American College of Cardiology.

[6]  H. Calkins,et al.  Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2 , 2006, Human mutation.

[7]  P. Syrris,et al.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. , 2006, American journal of human genetics.

[8]  J. Gärtner,et al.  Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients , 2006, Human mutation.

[9]  G. Breithardt,et al.  Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice , 2006, Circulation.

[10]  S. Russell,et al.  Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[11]  Hugh Calkins,et al.  Desmosomal Dysfunction due to Mutations in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2006, Circulation research.

[12]  D. Panagiotakos,et al.  Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis. , 2006, European heart journal.

[13]  D. Roden,et al.  Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family. , 2006, Heart rhythm.

[14]  G. Danieli,et al.  Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. , 2006, European heart journal.

[15]  Hugh Calkins,et al.  DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2006, American journal of human genetics.

[16]  M. Horie,et al.  Novel mutation of plakophilin-2 associated with arrhythmogenic right ventricular cardiomyopathy. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[17]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. , 2006, Circulation.

[18]  S. Russell,et al.  Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2 , 2006, Circulation.

[19]  R. Hauer,et al.  Plakophilin-2 Mutations Are the Major Determinant of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2006, Circulation.

[20]  G. Danieli,et al.  Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.

[21]  S. Priori,et al.  Role of Genetic Analyses in Cardiology: Part I: Mendelian Diseases: Cardiac Channelopathies , 2006, Circulation.

[22]  P. Elliott,et al.  Clinical Expression of Plakophilin-2 Mutations in Familial Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.

[23]  D. Kelsell,et al.  Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome , 2005, Journal of Medical Genetics.

[24]  D. Judge,et al.  Marfan's syndrome , 2005, The Lancet.

[25]  M. Simpson,et al.  Novel Mutation in Desmoplakin Causes Arrhythmogenic Left Ventricular Cardiomyopathy , 2005, Circulation.

[26]  P. Syrris,et al.  Genetics of Right Ventricular Cardiomyopathy , 2005, Journal of cardiovascular electrophysiology.

[27]  G. Danieli,et al.  Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. , 2005, European heart journal.

[28]  B. Wranne,et al.  Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy – a scintigraphic and echocardiographic study , 2005, Clinical physiology and functional imaging.

[29]  S. Nattel,et al.  Arrhythmogenic right ventricular dysplasia type 1 and mutations in transforming growth factor beta3 gene regulatory regions: a breakthrough? , 2005, Cardiovascular research.

[30]  A. Bassett,et al.  The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). , 2005, Journal of the American College of Cardiology.

[31]  Gian Antonio Danieli,et al.  Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. , 2005, Cardiovascular Research.

[32]  S. Sen-Chowdhry,et al.  Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. , 2004, The American journal of medicine.

[33]  Walter Birchmeier,et al.  Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy , 2004, Nature Genetics.

[34]  G. Thiene,et al.  Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). , 2004, Heart rhythm.

[35]  H. Ostrer,et al.  Founder mutations among the Dutch , 2004, European Journal of Human Genetics.

[36]  M. Link,et al.  Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[37]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[38]  S. Rosenheck,et al.  Arrhythmogenic Right Ventricular Dysplasia A Recessive Mutation in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia, Skin Disorder, and Woolly Hair , 2003 .

[39]  F. Morady,et al.  Cardiac Sarcoidosis Masquerading as Right Ventricular Dysplasia , 2003, Pacing and clinical electrophysiology : PACE.

[40]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[41]  F. Marcus,et al.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2000, Circulation.

[42]  G. Danieli,et al.  Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.

[43]  M. S. Hamid,et al.  Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. , 2002, Journal of the American College of Cardiology.

[44]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[45]  G. Danieli,et al.  Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[46]  D. Kelsell,et al.  Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. , 2000, Human molecular genetics.

[47]  W. Mckenna,et al.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Need for an international registry (Reprinted from Circulation Online, March 21, pg E101, 2000) , 2000 .

[48]  A. Crosby,et al.  Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.

[49]  S. Oruganti,et al.  Arrhythmogenic right ventricular dysplasia. , 1999, Circulation.

[50]  H Niimura,et al.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.

[51]  J. Cummings,et al.  Huntington's disease. , 1997, The Psychiatric clinics of North America.

[52]  M. Davies,et al.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[53]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[54]  P. Gallagher,et al.  Arrhythmogenic right ventricular cardiomyopathy , 1993, The Journal of pathology.

[55]  J. Perloff,et al.  Familial occurrence of right ventricular dysplasia: a study involving nine families. , 1988, Journal of the American College of Cardiology.

[56]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.